ARGOS THERAPEUTICS

Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

ARGOS THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

1997-01-01

Address:

Durham, North Carolina, United States

Country:

United States

Website Url:

http://www.argostherapeutics.com

Total Employee:

101+

Status:

Active

Contact:

(919) 287-6300

Email Addresses:

[email protected]

Total Funding:

238.93 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Euro IPv6 Contact Form 7

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

nabgen-logo

NabGen

NabGen develops therapy to overcome pre-existing immunity and re-administration barriers of gene therapies based on adeno-associated virus.

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.

tapimmune-logo

TapImmune

TapImmune develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.

Current Advisors List

hubert-birner_image

Hubert Birner Board Chairman @ Argos Therapeutics
Board_member
2005-01-01

isaac-cheng_image

Isaac Cheng Board Observer @ Argos Therapeutics
Board_observer

robert-carey_image

Robert Carey Board Member @ Argos Therapeutics
Board_member
2015-09-01

not_available_image

Irackly Mtibelishvily Board Member @ Argos Therapeutics
Board_member
2016-01-01

richard-morrison_image

Richard Morrison Board Member @ Argos Therapeutics
Board_member
2017-09-01

sander-van-deventer_image

Sander van Deventer Board Member @ Argos Therapeutics
Board_member
2001-01-01

jeffrey-d-abbey_image

Jeffrey D. Abbey Board Member @ Argos Therapeutics
Board_member
2010-02-01

chris-kroeger_image

Chris Kroeger Board of Observer @ Argos Therapeutics
Board_observer

Current Employees Featured

not_available_image

Charles A. Nicolette
Charles A. Nicolette Chief Scientific Officer and VP, Research and Development @ Argos Therapeutics
Chief Scientific Officer and VP, Research and Development

not_available_image

Doug Plessinger
Doug Plessinger Vice President, Clinical and Medical Affairs @ Argos Therapeutics
Vice President, Clinical and Medical Affairs
2011-01-01

not_available_image

Richard D. Katz,
Richard D. Katz, Chief Financial Officer @ Argos Therapeutics
Chief Financial Officer

not_available_image

Joan C. Winterbottom
Joan C. Winterbottom Chief Human Resources Officer @ Argos Therapeutics
Chief Human Resources Officer
2015-02-01

david-w-gryska_image

David W. Gryska
David W. Gryska Director @ Argos Therapeutics
Director
2010-11-01

phil-tracy_image

Phil Tracy
Phil Tracy Director @ Argos Therapeutics
Director

brian-j-underdown-phd_image

Brian J. Underdown, Ph.D.
Brian J. Underdown, Ph.D. Director @ Argos Therapeutics
Director

Founder

ralph-m-steinman_image

Ralph M. Steinman

Stock Details

Company's stock symbol is OTCQB:ARGS

Investors List

pharmstandard_image

Official Site Inspections

http://www.argostherapeutics.com Semrush global rank: 3.9 M Semrush visits lastest month: 3.27 K

Host Informations
Whois Informations

Loading ...

ARGOS THERAPEUTICS

ARGOS THERAPEUTICS

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Adamas Pharmaceuticals

Akebia Therapeutics

Apellis Pharmaceuticals

Excision BioTherapeutics

NabGen

Pandion Therapeutics

TapImmune

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Pharmstandard

Inbio Ventures

Horizon Technology Finance

Morningside Group

Forbion Capital Partners

Caisse de Depot et Placement du Quebec

TVM Capital

Pharmstandard International

Intersouth Partners

yet2Ventures

Official Site Inspections

More informations about "Argos Therapeutics" on Search Engine

America

Europe

Asia

Others

ARGOS THERAPEUTICS

ARGOS THERAPEUTICS

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Official Site Inspections

More informations about "Argos Therapeutics" on Search Engine